CN Patent
CN114681432B — 一种丁苯酞组合物及其用途
Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2024-07-02 · 2y expired
What this patent protects
本公开提供了一种经口腔黏膜递送的丁苯酞组合物,所述组合物包含丁苯酞100重量份,溶解稳定剂50~1000重量份,矫味剂0.1~200重量份;其中,所述溶解稳定剂是指能够显著提高丁苯酞在唾液中溶解稳定性的基于脂肪醇或脂肪酸的表面活性剂。本公开所述的丁苯酞组合物可经口腔颊粘膜、舌下黏膜递送,显著提高丁苯酞的吸收和生物利用度。
USPTO Abstract
本公开提供了一种经口腔黏膜递送的丁苯酞组合物,所述组合物包含丁苯酞100重量份,溶解稳定剂50~1000重量份,矫味剂0.1~200重量份;其中,所述溶解稳定剂是指能够显著提高丁苯酞在唾液中溶解稳定性的基于脂肪醇或脂肪酸的表面活性剂。本公开所述的丁苯酞组合物可经口腔颊粘膜、舌下黏膜递送,显著提高丁苯酞的吸收和生物利用度。
Drugs covered by this patent
- Lipitor (Atorvastatin Calcium) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.